BioNTech To Price Vaccine Below Market Rates, Differentiate Between Regions
1 sourceUpdated Nov 10, 2020
BioNTech, first in the race to produce evidence of a working COVID-19 vaccine, is planning to price the two-shot regimen below “typical market rates” and would differentiate pricing between countries or regions…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup